Chen et al. studied the TILs in the baseline tumor tissues of 25 patients with early stage and 35 patients with advanced NSCLC and discovered a new subgroup accumulating in the TME, namely, CD8+ TILs. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.